Floatz logo

Saxagliptin

Disorder of Glucose Regulation

Woman'sSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Disorder of Glucose Regulation cohort.

Asset / SponsorPhaseRating
Metformin
SINA Health Education and Welfare Trust
Phase 4BBB
ZIDOVUDINE
Kirby Institute
Phase 4BB
Empagliflozin
SINA Health Education and Welfare Trust
Phase 4BB
Exenatide
RenJi Hospital
Phase 4BB
Glargine
Federico II University
Phase 4BB

View all 28 →

Same molecule, other indications

Saxagliptin is also rated in:

type 2 diabetes mellitusDormant
BBB
Indicative ·
75 / 100
View asset →
prediabetes syndromeDormant
BB
Indicative ·
68 / 100
View asset →
acute myocardial infarctionDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →